Inventor · disambiguated record
Ofra Kessler
Also filed as: KESSLER OFRA
6 granted patents·3 pending applications·3 citations·filing 2008–2021
71Inventor score
Files withNEUFELD GERA3RAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES2MEDICAL RES & DEVELOPMENT FUND FOR HEALTH SERVICES BNAI ZION MEDICAL CENTER1RAPPAPORT FAMILY INST FOR RES1RAPPAPORT FAMILY INST FOR RES IN THE MEDICAL SCIENCES1
Top patents by PatentIndex Score
9 records- 0170US9896490B2Semaphorin 3C variants, compositions comprising said variants and methods of use thereofRAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES·Filed 2014·Granted Feb 20, 2018·1 cites·25 claims
- 0269US8088735B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofNEUFELD GERA·Filed 2008·Granted Jan 3, 2012·1 cites·9 claims
- 0367US8513194B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofNEUFELD GERA·Filed 2011·Granted Aug 20, 2013·1 cites·6 claims
- 0454US9808506B2Compositions comprising semaphorins for the treatment of cancer and methods of selection thereofRAPPAPORT FAMILY INST FOR RES IN THE MEDICAL SCIENCES·Filed 2015·Granted Nov 7, 2017·0 cites·15 claims
- 0554US9155781B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofRAPPAPORT FAMILY INST FOR RES·Filed 2013·Granted Oct 13, 2015·0 cites·8 claims
- 0653US2018055907A1Compositions comprising semaphorins for the treatment of cancer and methods of selection thereofRAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES·Filed 2017·Application pending·0 cites
- 0750US2023272020A1Modified semaphorin 3a, compositions comprising the same and uses thereofMEDICAL RES & DEVELOPMENT FUND FOR HEALTH SERVICES BNAI ZION MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 0838US10561707B2Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseasesTECHNION RES & DEV FOUNDATION·Filed 2017·Granted Feb 18, 2020·0 cites·20 claims
- 0937US2013330349A1High affinity molecules capable of binding a type a plexin receptor and uses of sameNEUFELD GERA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ofra Kessler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →